Anatara Lifesciences Statistics

Total Valuation

ASX:ANR has a market cap or net worth of AUD 1.17 million. The enterprise value is 71,890.

Market Cap	1.17M
Enterprise Value	71,890

Important Dates

The next estimated earnings date is Friday, May 23, 2025.

Earnings Date	May 23, 2025
Ex-Dividend Date	n/a

Share Statistics

ASX:ANR has 213.38 million shares outstanding. The number of shares has increased by 52.75% in one year.

Current Share Class	n/a
Shares Outstanding	213.38M
Shares Change (YoY)	+52.75%
Shares Change (QoQ)	+12.51%
Owned by Insiders (%)	13.75%
Owned by Institutions (%)	13.33%
Float	125.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.68
PB Ratio	0.87
P/TBV Ratio	0.87
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.04
EV / Sales	0.29
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.42

Current Ratio	4.42
Quick Ratio	4.29
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -147.32% and return on invested capital (ROIC) is -92.48%.

Return on Equity (ROE)	-147.32%
Return on Assets (ROA)	-76.07%
Return on Invested Capital (ROIC)	-92.48%
Return on Capital Employed (ROCE)	-142.58%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.16
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -88.37% in the last 52 weeks. The beta is 0.66, so ASX:ANR's price volatility has been lower than the market average.

Beta (5Y)	0.66
52-Week Price Change	-88.37%
50-Day Moving Average	0.02
200-Day Moving Average	0.04
Relative Strength Index (RSI)	19.60
Average Volume (20 Days)	4,479,768

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:ANR had revenue of AUD 250,513 and -1.93 million in losses. Loss per share was -0.01.

Revenue	250,513
Gross Profit	-1.07M
Operating Income	-1.94M
Pretax Income	-1.93M
Net Income	-1.93M
EBITDA	-1.94M
EBIT	-1.94M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 1.10 million in cash and n/a in debt, giving a net cash position of 1.10 million or 0.01 per share.

Cash & Cash Equivalents	1.10M
Total Debt	n/a
Net Cash	1.10M
Net Cash Per Share	0.01
Equity (Book Value)	1.36M
Book Value Per Share	0.01
Working Capital	1.36M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-1.86M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-775.12%
Pretax Margin	-771.67%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ASX:ANR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-52.75%
Shareholder Yield	-52.75%
Earnings Yield	-164.72%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASX:ANR has an Altman Z-Score of -8.73. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.73
Piotroski F-Score	n/a